2.07 USD
-0.02 (-0.96%)
Last: Jan 30, 2026, 10:15 AM
Taking everything into account, BTMD scores 5 out of 10 in our fundamental rating. BTMD was compared to 190 industry peers in the Pharmaceuticals industry. BTMD has an average financial health and profitability rating. BTMD scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- In the past year BTMD was profitable.
- BTMD had a positive operating cash flow in the past year.
- BTMD had positive earnings in 4 of the past 5 years.
- BTMD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 25.87%, BTMD belongs to the top of the industry, outperforming 98.42% of the companies in the same industry.
- The Return On Invested Capital of BTMD (45.22%) is better than 99.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 25.87% | ||
| ROE | N/A | ||
| ROIC | 45.22% |
ROA(3y)1.27%
ROA(5y)30.69%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- BTMD has a better Profit Margin (14.72%) than 86.84% of its industry peers.
- BTMD's Profit Margin has declined in the last couple of years.
- BTMD's Operating Margin of 16.09% is amongst the best of the industry. BTMD outperforms 85.79% of its industry peers.
- In the last couple of years the Operating Margin of BTMD has declined.
- The Gross Margin of BTMD (72.23%) is better than 78.95% of its industry peers.
- BTMD's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.09% | ||
| PM (TTM) | 14.72% | ||
| GM | 72.23% |
OM growth 3Y-13.56%
OM growth 5Y-5.58%
PM growth 3Y-59.09%
PM growth 5Y-39.26%
GM growth 3Y2.76%
GM growth 5Y3.16%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BTMD is creating value.
- BTMD has less shares outstanding than it did 1 year ago.
- The debt/assets ratio for BTMD is higher compared to a year ago.
2.2 Solvency
- BTMD has an Altman-Z score of 2.21. This is not the best score and indicates that BTMD is in the grey zone with still only limited risk for bankruptcy at the moment.
- BTMD has a Altman-Z score of 2.21. This is in the better half of the industry: BTMD outperforms 61.05% of its industry peers.
- BTMD has a debt to FCF ratio of 4.18. This is a neutral value as BTMD would need 4.18 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 4.18, BTMD belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 4.18 | ||
| Altman-Z | 2.21 |
ROIC/WACC4.84
WACC9.34%
2.3 Liquidity
- A Current Ratio of 1.01 indicates that BTMD should not have too much problems paying its short term obligations.
- BTMD has a worse Current ratio (1.01) than 84.21% of its industry peers.
- BTMD has a Quick Ratio of 1.01. This is a bad value and indicates that BTMD is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of BTMD (0.72) is worse than 85.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
- BTMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 190.00%, which is quite impressive.
- The earnings per share for BTMD have been decreasing by -48.53% on average. This is quite bad
- The Revenue for BTMD has decreased by -18.44% in the past year. This is quite bad
- The Revenue has been growing by 12.38% on average over the past years. This is quite good.
EPS 1Y (TTM)190%
EPS 3Y-71.33%
EPS 5Y-48.53%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-18.44%
Revenue growth 3Y12.26%
Revenue growth 5Y12.38%
Sales Q2Q%-6.67%
3.2 Future
- The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
- Based on estimates for the next years, BTMD will show a small growth in Revenue. The Revenue will grow by 6.89% on average per year.
EPS Next Y229.18%
EPS Next 2Y7.66%
EPS Next 3Y9.09%
EPS Next 5Y41.42%
Revenue Next Year-3.44%
Revenue Next 2Y-0.37%
Revenue Next 3Y2.36%
Revenue Next 5Y6.89%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- BTMD is valuated cheaply with a Price/Earnings ratio of 2.38.
- Compared to the rest of the industry, the Price/Earnings ratio of BTMD indicates a rather cheap valuation: BTMD is cheaper than 97.89% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of BTMD to the average of the S&P500 Index (28.39), we can say BTMD is valued rather cheaply.
- With a Price/Forward Earnings ratio of 8.12, the valuation of BTMD can be described as very reasonable.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of BTMD indicates a rather cheap valuation: BTMD is cheaper than 91.05% of the companies listed in the same industry.
- BTMD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.38 | ||
| Fwd PE | 8.12 |
4.2 Price Multiples
- 95.79% of the companies in the same industry are more expensive than BTMD, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, BTMD is valued cheaply inside the industry as 98.95% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.75 | ||
| EV/EBITDA | 5.98 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- BTMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y7.66%
EPS Next 3Y9.09%
5. Dividend
5.1 Amount
- No dividends for BTMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIOTE CORP -A / BTMD FAQ
Can you provide the ChartMill fundamental rating for BIOTE CORP -A?
ChartMill assigns a fundamental rating of 5 / 10 to BTMD.
Can you provide the valuation status for BIOTE CORP -A?
ChartMill assigns a valuation rating of 9 / 10 to BIOTE CORP -A (BTMD). This can be considered as Undervalued.
Can you provide the profitability details for BIOTE CORP -A?
BIOTE CORP -A (BTMD) has a profitability rating of 6 / 10.
How financially healthy is BIOTE CORP -A?
The financial health rating of BIOTE CORP -A (BTMD) is 4 / 10.
How sustainable is the dividend of BIOTE CORP -A (BTMD) stock?
The dividend rating of BIOTE CORP -A (BTMD) is 0 / 10 and the dividend payout ratio is 0%.